Genedata Biologics
Biotherapeutics Discovery
Receive your quote directly from the manufacturer.
Genedata Biologics® is a first-in-class workflow system that increases efficiency, throughput, and quality during the biologics discovery process. Uniquely designed for biotherapeutics and novel modalities, including bispecifics, TCRs, CAR-Ts, AAVs, RNAs, and ADCs, the system supports the entire research process – from screening, engineering, and production to developability and manufacturability assessment.
Automating MS-based workflows to accelerate antibody-drug conjugate discovery
This case study describes how Merck streamlined antibody-drug conjugate (ADC) discovery by implementing the Genedata Biopharma Platform to automate mass spectrometry (MS)-based workflows. The solution integrates data from multiple analytical techniques, enabling consistent, real-time access to molecular and analytical information across global research sites.
By centralizing data and automating workflows, the platform eliminates manual data handling and reduces the risk of human error. It enables high-throughput processing of ADC samples, automatic calculation of key attributes such as drug-to-antibody ratio (DAR), and improved traceability across the discovery pipeline. This approach supports faster decision-making, improved data accessibility, and more efficient identification of promising ADC candidates.
Resource details:
- Resource type: Case study
- Page count: 2
- Read time: 3 mins
Simplifying deep antibody mining for maximum impact
Wednesday, September 9 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
In this SelectScience® webinar, learn how OmniAb is transforming antibody discovery by combining high-throughput functional screening with Genedata Biologics to streamline data integration, improve decision-making, and transform therapeutic development.
Bob Chen, Vice President, Discovery Systems at OmniAb, will present how the company’s proprietary xPloration® platform accelerates antibody discovery by enabling the rapid evaluation of millions of candidates and identifying thousands of promising hits within minutes. By integrating with Genedata Biologics — serving as the central bioregistration and data management hub — scientists can effortlessly link assay data such as ELISA, flow cytometry, and SPR with corresponding sequence information.
Discover how this centralized data framework ensures data consistency, enhances traceability, and delivers actionable insights that drive efficiency and prevision across the entire discovery workflow.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Webinar details
Cost: Free to attend
Location: Online
Duration: 60 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
How can scientists unlock deeper insights from antibody discovery data?
Join experts from OmniAb and Genedata to discover how integrated data workflows, high-throughput screening, and advanced analytics are helping researchers accelerate antibody discovery and identify promising therapeutic candidates with greater confidence
